General Information of the Protein
Protein ID
PT05723
Protein Name
Reduced folate transporter
Secondarily
Protein Name
Cyclic dinucleotide:anion antiporter SLC19A1
Folate:anion antiporter SLC19A1
Intestinal folate carrier 1
Placental folate transporter
Reduced folate carrier protein
Reduced folate transporter 1
Solute carrier family 19 member 1
Gene Name
SLC19A1
Secondarily
Gene Name
FLOT1
RFC1
Sequence
MVPSSPAVEKQVPVEPGPDPELRSWRHLVCYLCFYGFMAQIRPGESFITPYLLGPDKNFTREQVTNEITPVLSYSYLAVLVPVFLLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSVTMAARIAYSSYIFSLVRPARYQRVAGYSRAAVLLGVFTSSVLGQLLVTVGRVSFSTLNYISLAFLTFSVVLALFLKRPKRSLFFNRDDRGRCETSASELERMNPGPGGKLGHALRVACGDSVLARMLRELGDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVDPTTNSARVYNGAADAASTLLGAITSFAAGFVKIRWARWSKLLIAGVTATQAGLVFLLAHTRHPSSIWLCYAAFVLFRGSYQFLVPIATFQIASSLSKELCALVFGVNTFFATIVKTIITFIVSDVRGLGLPVRKQFQLYSVYFLILSIIYFLGAMLDGLRHCQRGHHPRQPPAQGLRSAAEEKAAQALSVQDKGLGGLQPAQSPPLSPEDSLGAVGPASLEQRQSDPYLAQAPAPQAAEFLSPVTTPSPCTLCSAQASGPEAADETCPQLAVHPPGVSKLGLQCLPSDGVQNVNQ
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Transporter
>
Electrochemical transporter
>
SLC superfamily of solute carriers
>
SLC19 family of vitamin transporters
Function
Antiporter that mediates the import of reduced folates or a subset of cyclic dinucleotides, driven by the export of organic anions (PubMed:7826387, PubMed:9041240, PubMed:10787414, PubMed:15337749, PubMed:16115875, PubMed:22554803, PubMed:31511694, PubMed:31126740, PubMed:32276275). Mechanistically, acts as a secondary active transporter, which exports intracellular organic anions down their concentration gradients to facilitate the uptake of its substrates (PubMed:22554803, PubMed:31511694, PubMed:31126740). Has high affinity for N5-methyltetrahydrofolate, the predominant circulating form of folate (PubMed:10787414, PubMed:14609557, PubMed:22554803). Also able to mediate the import of antifolate drug methotrexate (PubMed:7615551, PubMed:7641195, PubMed:9767079, PubMed:22554803). Also acts as an importer of immunoreactive cyclic dinucleotides, such as cyclic GMP-AMP (2'-3'-cGAMP), an immune messenger produced in response to DNA virus in the cytosol, and its linkage isomer 3'-3'-cGAMP, thus playing a role in triggering larger immune responses (PubMed:31511694, PubMed:31126740). 5-amino-4-imidazolecarboxamide riboside (AICAR), when phosphorylated to AICAR monophosphate, can serve as an organic anion for antiporter activity (PubMed:22554803).
    Show/Hide
Uniprot ID
Primary ID:
P41440

Secondarily ID:
B2R7U8
B7Z8C3
E9PFY4
O00553
O60227
Q13026
Q9BTX8
    Show/Hide
Ensembl ID
ENSG00000173638
HGNC ID
HGNC:10937
Subcellular Location
Cell membrane
Apical cell membrane
Basolateral cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL001007 , Chinese hamster PC43-10
Compound ID Compound Name Compound Formula
CP0041026
(2S)-2-[(5-{methyl[(2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)formamido]pentanedioic acid
   Show/Hide
C21H22N4O6S
 1
1
IC50 = 6.3 nM
   TI
   LI
   LO
   TS
CP0036197
2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid
   Show/Hide
C20H22N8O5
 1
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
CP0381988
(2S)-2-[[5-[4-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)butyl]thiophene-2-carbonyl]amino]pentanedioic acid
   Show/Hide
C20H23N5O6S
 1
1
IC50 = 38.3 nM
   TI
   LI
   LO
   TS
CP0374709
(2S)-2-[[4-[3-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)propyl]thiophene-2-carbonyl]amino]pentanedioic acid
   Show/Hide
C19H21N5O6S
 1
1
IC50 = 54 nM
   TI
   LI
   LO
   TS
CP0468983
(2S)-2-[[5-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]thiophene-2-carbonyl]amino]pentanedioic acid
   Show/Hide
C18H19N5O6S
 1
1
IC50 = 59.8 nM
   TI
   LI
   LO
   TS
CP0055020
AGF94
   Show/Hide
C19H21N5O6S
 1
1
IC50 = 101 nM
   TI
   LI
   LO
   TS
CP0461015
(2S)-2-[[5-[3-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)propyl]thiophene-2-carbonyl]amino]pentanedioic acid
   Show/Hide
C19H21N5O6S
 1
1
IC50 = 116 nM
   TI
   LI
   LO
   TS
CP0036368
(2S)-2-{[4-(2-{2-amino-4-oxo-1H,4H,7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethyl)phenyl]formamido}pentanedioic acid
   Show/Hide
C20H21N5O6
 1
1
IC50 = 138 nM
   TI
   LI
   LO
   TS
CP0206826
(2S)-2-[[5-[3-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-6-yl)propyl]thiophene-3-carbonyl]amino]pentanedioic acid
   Show/Hide
C19H21N5O6S
 1
1
IC50 = 189 nM
   TI
   LI
   LO
   TS
CP0374708
(2S)-2-[[4-[3-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-6-yl)propyl]thiophene-2-carbonyl]amino]pentanedioic acid
   Show/Hide
C19H21N5O6S
 1
1
IC50 = 197 nM
   TI
   LI
   LO
   TS
CP0399631
(2S)-2-[[5-[5-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)pentyl]thiophene-2-carbonyl]amino]pentanedioic acid
   Show/Hide
C21H25N5O6S
 1
1
IC50 = 243.2 nM
   TI
   LI
   LO
   TS
CP0379858
(2S)-2-[[5-[3-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-6-yl)propyl]thiophene-2-carbonyl]amino]pentanoic acid
   Show/Hide
C19H23N5O4S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0386883
4-[[5-[3-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-6-yl)propyl]thiophene-2-carbonyl]amino]butanoic acid
   Show/Hide
C18H21N5O4S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0386884
(2S)-2-[[5-[3-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-6-yl)propyl]thiophene-2-carbonyl]amino]hexanedioic acid
   Show/Hide
C20H23N5O6S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0411313
5-[3-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-6-yl)propyl]thiophene-2-carboxylic acid
   Show/Hide
C14H14N4O3S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0419800
(2S)-2-[[5-[3-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-6-yl)propyl]thiophene-2-carbonyl]amino]butanedioic acid
   Show/Hide
C18H19N5O6S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0200251
(2S)-2-[[5-[(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)methyl]thiophene-2-carbonyl]amino]pentanedioic acid
   Show/Hide
C17H17N5O6S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0330758
(S)-2-({5-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]-pyrimidin-6-yl)-butyl]-thiophene-2-carbonyl}-amino)-pentanedioicAcid
   Show/Hide
C20H23N5O6S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0399627
(2S)-2-[[5-[6-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)hexyl]thiophene-2-carbonyl]amino]pentanedioic acid
   Show/Hide
C22H27N5O6S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0374710
(2S)-2-[[5-[3-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)propyl]thiophene-3-carbonyl]amino]pentanedioic acid
   Show/Hide
C19H21N5O6S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0036197
2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid
   Show/Hide
C20H22N8O5
 1
1 Ki = 3500 nM
Clinical Information about the Protein
Target 1 ( Solute carrier family 19 member 1 (SLC19A1) )
Target Type Successful Target
Disease 2 Target-related Diseases  2
1 Vitamin deficiency [ICD-11: 5B55-5B71]
2 leukaemia [ICD-11: 2A60-2B33]
Approved Drug(s) 2 Approved Drugs  2
1 Folic Acid Approved
Vitamin deficiency
2 Methotrexate Approved
leukaemia